KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,819,065 | -17.7% | 28,500 | +5.6% | 0.03% | -35.0% |
Q2 2023 | $5,854,950 | -32.8% | 27,000 | -43.8% | 0.04% | -52.4% |
Q1 2023 | $8,718,720 | +343.7% | 48,000 | +380.0% | 0.08% | +147.1% |
Q4 2022 | $1,965,000 | +34.4% | 10,000 | +53.8% | 0.03% | +112.5% |
Q3 2022 | $1,462,000 | -61.5% | 6,500 | -78.3% | 0.02% | -64.4% |
Q2 2022 | $3,795,000 | -25.2% | 30,000 | -25.0% | 0.04% | -26.2% |
Q1 2022 | $5,072,000 | -35.5% | 40,000 | -33.3% | 0.06% | -28.2% |
Q4 2021 | $7,860,000 | -5.8% | 60,000 | -12.0% | 0.08% | 0.0% |
Q3 2021 | $8,343,000 | +7.3% | 68,200 | 0.0% | 0.08% | +32.8% |
Q2 2021 | $7,774,000 | -5.2% | 68,200 | 0.0% | 0.06% | -17.9% |
Q1 2021 | $8,200,000 | +34.5% | 68,200 | +13.7% | 0.08% | +5.4% |
Q4 2020 | $6,095,000 | +12.6% | 60,000 | -14.3% | 0.07% | +5.7% |
Q3 2020 | $5,412,000 | +3.3% | 70,000 | +48.9% | 0.07% | -24.7% |
Q2 2020 | $5,239,000 | +29.0% | 47,000 | -16.7% | 0.09% | +38.8% |
Q1 2020 | $4,062,000 | -7.0% | 56,417 | -2.6% | 0.07% | -5.6% |
Q4 2019 | $4,366,000 | +328.5% | 57,951 | -7.2% | 0.07% | +343.8% |
Q3 2019 | $1,019,000 | -27.3% | 62,450 | -10.8% | 0.02% | +6.7% |
Q2 2019 | $1,401,000 | – | 70,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |